argenx SE reported $45.15B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AstraZeneca USD 301.25B 13.1B Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
UCB EUR 46.41B 13.94B Dec/2025